Gear up for the change! Allena Pharmaceuticals Inc. (ALNA) has hit the volume of 1030042 – Invest Chronicle
Home  »  Stock   »  Gear up for the change! Allena Pharmaceuticals Inc...

Gear up for the change! Allena Pharmaceuticals Inc. (ALNA) has hit the volume of 1030042

Let’s start up with the current stock price of Allena Pharmaceuticals Inc. (ALNA), which is $0.83 to be very precise. The Stock rose vividly during the last session to $0.8482 after opening rate of $0.797 while the lowest price it went was recorded $0.78 before closing at $0.82.

>> 7 Top Picks for the Post-Pandemic Economy << 

Recently in News on July 13, 2021, Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced that it has entered into definitive agreements with several healthcare-focused institutional and accredited investors for the purchase and sale of 21,357,744 shares of the Company’s common stock (or common stock equivalents) and warrants to purchase up to an aggregate of 10,678,872 shares of the Company’s common stock, at a purchase price of $1.311 per share of common stock (or common stock equivalent) and associated warrant, in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about July 16, 2021, subject to the satisfaction of customary closing conditions. You can read further details here


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Allena Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.7800 on 01/26/21, with the lowest value was $0.7700 for the same time period, recorded on 07/19/21.

Allena Pharmaceuticals Inc. (ALNA) full year performance was -56.81%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Allena Pharmaceuticals Inc. shares are logging -70.26% during the 52-week period from high price, and 7.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.77 and $2.78.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1030042 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Allena Pharmaceuticals Inc. (ALNA) recorded performance in the market was -35.55%, having the revenues showcasing -23.61% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 49.40M, as it employees total of 45 workers.

Analysts verdict on Allena Pharmaceuticals Inc. (ALNA)

During the last month, 3 analysts gave the Allena Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2727, with a change in the price was noted -0.86. In a similar fashion, Allena Pharmaceuticals Inc. posted a movement of -51.43% for the period of last 100 days, recording 1,307,415 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ALNA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.42.

>> 7 Top Picks for the Post-Pandemic Economy << 

Allena Pharmaceuticals Inc. (ALNA): Technical Analysis

Raw Stochastic average of Allena Pharmaceuticals Inc. in the period of last 50 days is set at 6.76%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 6.76%. In the last 20 days, the company’s Stochastic %K was 6.50% and its Stochastic %D was recorded 5.31%.

Let’s take a glance in the erstwhile performances of Allena Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -35.55%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -47.45%, alongside a downfall of -56.81% for the period of the last 12 months. The shares increased approximately by -40.65% in the 7-day charts and went down by -35.04% in the period of the last 30 days. Common stock shares were lifted by -23.61% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam